Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Accelerated TBE vaccination schedules for last-minute travelers
2019-000801-61Phase 3Completed
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Apr 2019
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of Tick-borne encephalitis vaccine in tick-borne encephalitis (TBE) (5 arms), sponsored by Institute of Tropical Medicine Antwerp. Primary endpoint: Seroconversion rate over time. Started Apr 2019; status: completed.
02
Drugs
Tick-borne encephalitis vaccine
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2019-000801-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000801-61.